Cancer-cell membrane (CCM) proteins such as EpCAM, E-cadherin, and integrin αvβ3 mediate adhesion to disseminated tumor cells (DTCs) in secondary organs, increasing nano-drug enrichment by 2–3-fold compared with PEGylated controls [49,51]. The gene discussed is EPCAM; the disease is cancer.